About AAT Bioquest
Founded in 2006, AAT Bioquest develops fluorescent dyes, molecular probes, assay kits and bioconjugation reagents for life science research, diagnostic development and drug discovery. The company specialises in fluorescence, luminescence and colorimetric detection technologies that enable researchers to study cellular function, molecular interactions and biochemical pathways. Its technologies support applications across cell biology, immunology, neuroscience, molecular biology, pharmacology and assay development, including fluorescence microscopy, flow cytometry, functional screening and high-content analysis.
AAT Bioquest offers a broad portfolio of research reagents covering cell viability, apoptosis, reactive oxygen species detection, calcium signalling, nucleic acid analysis and enzyme activity measurement. Key product families include iFluor® fluorescent dyes, Calbryte™ calcium indicators, ReadiLink™ antibody labelling kits, xtraFluor™ flow cytometry reagents, Gelite™ nucleic acid stains and Power Styramide™ signal amplification technologies. The company also provides assay development, bioconjugation and custom synthesis services to support the creation and optimisation of biochemical, cell-based and high-throughput screening workflows.
Europa Biosite subsidiaries distribute AAT Bioquest products in Denmark, Estonia, Finland, Germany, Ireland, Latvia, Lithuania, Norway, Sweden, Switzerland, United Kingdom.